Search Result "TCR recognition"
HLA and TCR Recognition of Medications in Severe Cutaneous Adverse Reactions
Journal: Current Immunology Reviews (Discontinued)
Volume: 10 Issue: 1 Year: 2014 Page: 51-61
Author(s): Ren-You Pan,Yi-Chih Wu,Wen-Hung Chung,Shuen-Iu Hung
The TCR/CD3 Complex: Opening the Gate to Successful Vaccination
Journal: Current Pharmaceutical Design
Volume: 15 Issue: 2 Year: 2009 Page: 3290-3300
Author(s): Pilar Portoles, Jose M. Rojo
Major Highlights of the CAR-TCR Summit, Boston, 2016
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17 Issue: 10 Year: 2017 Page: 1344-1350
Author(s): Vita Golubovskaya,Robert Berahovich,Shirley Xu,Hizkia Harto,Lijun Wu
Modulation of T Cell Immunity by TCR / pMHC Dwell Time and Activating / Inhibitory Receptor Pairs on the Antigen-Presenting Cell
Journal: Current Pharmaceutical Design
Volume: 9 Issue: 3 Year: 2003 Page: 233-244
Author(s): Alexis M. Kalergis
TCR Peptide Vaccination in Multiple Sclerosis: Boosting a Deficient Natural Regulatory Network that may Involve TCR-Specific CD4+CD25+ Treg Cells
Journal: Current Drug Targets - Inflammation & Allergy
Volume: 4 Issue: 2 Year: 2005 Page: 217-229
Author(s): Arthur A. Vandenbark
Pattern Recognition by CD6: A Scavenger-Like Lymphocyte Receptor
Journal: Current Drug Targets
Volume: 17 Issue: 6 Year: 2016 Page: 640-650
Author(s): Adelaida Sarukhan, Mario Martinez-Florensa, Cristina Escoda-Ferran, Esther Carrasco, Esther Carreras, Francisco Lozano
Recognition of Classical and Heavy Chain Forms of HLA-B27 by Leukocyte Receptors
Journal: Current Molecular Medicine
Volume: 4 Issue: 1 Year: 2004 Page: 59-65
Author(s): Rachel L. Allen, John Trowsdale
Recognition and Function of HumanγδT Cells: Application for Tumor Immunotherapy
Journal: Current Immunology Reviews
Volume: 1 Issue: 3 Year: 2005 Page: 275-285
Author(s): Yoshimasa Tanaka, Yu Kato, Shoichi Kita, Nagahiro Minato
Life or Death of T Cells with Antigen-Specific Receptors - Using T Cells for Cancer Adoptive Immunotherapy / Gene Therapy
Journal: Current Gene Therapy
Volume: 1 Issue: 3 Year: 2001 Page: 253-255
Author(s): L. Ren-Heidenreich, L. G. Lum
MHC Class I TCR Engineered Anti-Tumor CD4 T Cells: Implications For Cancer Immunotherapy
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 9 Issue: 4 Year: 2009 Page: 344-352
Author(s): Arvind Chhabra